Replimune Group, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
ASND
Ascendis Pharma A/S |
$152.98 | $7.77 B | -21.45 | 1017 |
AVTE
Aerovate Therapeutics, Inc. |
$2.47 | $597.48 M | -0.82 | 30 |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -16.47 | 355 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$34.47 | $3.53 B | -9.34 | 437 |
GOSS
Gossamer Bio, Inc. |
$1.45 | $124.06 M | -5.82 | 135 |
KRON
Kronos Bio, Inc. |
$0.94 | $44.62 M | -0.66 | 62 |
KROS
Keros Therapeutics, Inc. |
$11.58 | $1.76 B | -2.31 | 169 |
KURA
Kura Oncology, Inc. |
$7.14 | $1.66 B | -3.54 | 192 |
LYRA
Lyra Therapeutics, Inc. |
$0.17 | $19.53 M | -0.11 | 30 |
MLYS
Mineralys Therapeutics, Inc. |
$14.25 | $652.38 M | -3.89 | 51 |
MRUS
Merus N.V. |
$47.10 | $3.50 B | -14.07 | 260 |
NAMS
NewAmsterdam Pharma Company N.V. |
$23.37 | $1.74 B | -9.12 | 68 |
NUVL
Nuvalent, Inc. |
$77.01 | $5.11 B | -19.6 | 142 |
NVCT
Nuvectis Pharma, Inc. |
$8.85 | $116.38 M | -7.96 | 13 |
PRTC
PureTech Health plc |
$17.70 | $809.08 M | -5.9 | 90 |
PTGX
Protagonist Therapeutics, Inc. |
$54.78 | $2.04 B | 12.96 | 126 |
SNDX
Syndax Pharmaceuticals, Inc. |
$12.95 | $1.66 B | -3.48 | 270 |
UTHR
United Therapeutics Corporation |
$307.24 | $12.20 B | 12.46 | 1305 |
VTYX
Ventyx Biosciences, Inc. |
$1.41 | $229.83 M | -0.72 | 79 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
